TD Asset Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $12.5M | Sell |
57,805
-69,463
| -55% | -$13.3M | 0.01% | 606 |
|
|
2026
Q1 | $23.3M | Sell |
127,268
-8,084
| -6% | -$1.49M | 0.02% | 483 |
|
|
2025
Q4 | $23.8M | Sell |
135,352
-25,843
| -16% | -$4.22M | 0.02% | 483 |
|
|
2025
Q3 | $22.6M | Buy |
161,195
+18,168
| +13% | +$2.46M | 0.02% | 483 |
|
|
2025
Q2 | $18M | Sell |
143,027
-141,349
| -50% | -$17.6M | 0.02% | 514 |
|
|
2025
Q1 | $38.9M | Sell |
284,376
-71,330
| -20% | -$10.2M | 0.04% | 366 |
|
|
2024
Q4 | $54.4M | Sell |
355,706
-15,295
| -4% | -$2.58M | 0.05% | 301 |
|
|
2024
Q3 | $72.2M | Sell |
371,001
-9,787
| -3% | -$2.05M | 0.06% | 258 |
|
|
2024
Q2 | $88.3M | Buy |
380,788
+13,552
| +4% | +$2.95M | 0.08% | 208 |
|
|
2024
Q1 | $79.2M | Sell |
367,236
-22,748
| -6% | -$5.33M | 0.07% | 231 |
|
|
2023
Q4 | $101M | Buy |
389,984
+108,956
| +39% | +$26.8M | 0.1% | 180 |
|
|
2023
Q3 | $72.2M | Buy |
281,028
+64,844
| +30% | +$17.3M | 0.09% | 185 |
|
|
2023
Q2 | $61.6M | Buy |
216,184
+60,325
| +39% | +$18M | 0.07% | 222 |
|
|
2023
Q1 | $43.3M | Sell |
155,859
-3,860
| -2% | -$1.07M | 0.05% | 278 |
|
|
2022
Q4 | $44.2M | Sell |
159,719
-4,732
| -3% | -$1.34M | 0.05% | 278 |
|
|
2022
Q3 | $43.5M | Buy |
164,451
+10,013
| +6% | +$2.13M | 0.05% | 274 |
|
|
2022
Q2 | $31.5M | Buy |
154,438
+8,049
| +5% | +$1.65M | 0.04% | 331 |
|
|
2022
Q1 | $30.8M | Sell |
146,389
-3,095
| -2% | -$673K | 0.03% | 388 |
|
|
2021
Q4 | $35.9M | Buy |
149,484
+2,555
| +2% | +$657K | 0.03% | 381 |
|
|
2021
Q3 | $41.6M | Buy |
146,929
+25,319
| +21% | +$8.3M | 0.04% | 316 |
|
|
2021
Q2 | $39.7M | Sell |
121,610
-11,425
| -9% | -$3.46M | 0.04% | 341 |
|
|
2021
Q1 | $37.2M | Buy |
133,035
+2,213
| +2% | +$597K | 0.04% | 334 |
|
|
2020
Q4 | $32M | Buy |
130,822
+16,821
| +15% | +$4.34M | 0.04% | 331 |
|
|
2020
Q3 | $32.3M | Buy |
114,001
+24,029
| +27% | +$6.7M | 0.04% | 291 |
|
|
2020
Q2 | $24.1M | Sell |
89,972
-35,196
| -28% | -$10.6M | 0.03% | 328 |
|
|
2020
Q1 | $39.6M | Buy |
125,168
+29,669
| +31% | +$9M | 0.07% | 208 |
|
|
2019
Q4 | $28.3M | Buy |
95,499
+11,356
| +13% | +$3.15M | 0.04% | 323 |
|
|
2019
Q3 | $19.6M | Sell |
84,143
-4,870
| -5% | -$1.13M | 0.03% | 372 |
|
|
2019
Q2 | $20.8M | Buy |
89,013
+1,557
| +2% | +$360K | 0.03% | 368 |
|
|
2019
Q1 | $20.7M | Sell |
87,456
-22,018
| -20% | -$6.93M | 0.03% | 361 |
|
|
2018
Q4 | $32.9M | Sell |
109,474
-3,548
| -3% | -$1.13M | 0.06% | 258 |
|
|
2018
Q3 | $39.9M | Sell |
113,022
-6,313
| -5% | -$2.17M | 0.06% | 254 |
|
|
2018
Q2 | $34.6M | Sell |
119,335
-37,379
| -24% | -$10.5M | 0.05% | 270 |
|
|
2018
Q1 | $42.9M | Sell |
156,714
-16,996
| -10% | -$5.28M | 0.07% | 236 |
|
|
2017
Q4 | $55.3M | Sell |
173,710
-13,115
| -7% | -$4.21M | 0.08% | 192 |
|
|
2017
Q3 | $58.5M | Buy |
186,825
+7,651
| +4% | +$2.27M | 0.09% | 181 |
|
|
2017
Q2 | $48.6M | Sell |
179,174
-10,761
| -6% | -$2.85M | 0.08% | 203 |
|
|
2017
Q1 | $51.9M | Sell |
189,935
-3,790
| -2% | -$1.07M | 0.08% | 196 |
|
|
2016
Q4 | $54.9M | Sell |
193,725
-10,841
| -5% | -$3.21M | 0.09% | 184 |
|
|
2016
Q3 | $64M | Buy |
204,566
+7,816
| +4% | +$2.31M | 0.11% | 162 |
|
|
2016
Q2 | $47.6M | Sell |
196,750
-8,458
| -4% | -$2.23M | 0.09% | 198 |
|
|
2016
Q1 | $53.4M | Sell |
205,208
-17,561
| -8% | -$4.64M | 0.1% | 171 |
|
|
2015
Q4 | $68.2M | Buy |
222,769
+12,149
| +6% | +$3.49M | 0.14% | 132 |
|
|
2015
Q3 | $61.5M | Sell |
210,620
-50,400
| -19% | -$16.6M | 0.12% | 145 |
|
|
2015
Q2 | $105M | Sell |
261,020
-9,244
| -3% | -$3.71M | 0.19% | 105 |
|
|
2015
Q1 | $114M | Sell |
270,264
-16,436
| -6% | -$6.48M | 0.21% | 100 |
|
|
2014
Q4 | $97.3M | Sell |
286,700
-5,836
| -2% | -$1.89M | 0.16% | 117 |
|
|
2014
Q3 | $96.8M | Buy |
292,536
+21,797
| +8% | +$7.19M | 0.17% | 106 |
|
|
2014
Q2 | $85.4M | Sell |
270,739
-8,400
| -3% | -$2.53M | 0.15% | 124 |
|
|
2014
Q1 | $85.4M | Buy |
279,139
+9,474
| +4% | +$3.01M | 0.16% | 117 |
|
|
2013
Q4 | $75.4M | Buy |
269,665
+9,500
| +4% | +$2.46M | 0.14% | 128 |
|
|
2013
Q3 | $62.6M | Sell |
260,165
-4,800
| -2% | -$1.07M | 0.12% | 140 |
|
|
2013
Q2 | $57M | Buy |
+264,965
| New | +$56.6M | 0.12% | 136 |
|
Other funds holding BIIB
VCM
VPM
TD Asset Management's BIIB Position: Q2 2026 in Review
TD Asset Management reduced its Biogen (BIIB) stake by 55% in Q2 2026, selling an estimated $13.3M and leaving 57,805 shares worth $12.5M. The position accounts for 0.01% of the portfolio, ranked #606.
TD Asset Management first reported a position in BIIB in Q2 2013 and has held it in 53 quarters since. The position peaked at $114M in Q1 2015. 842 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.
- TD Asset Management held 57,805 shares of Biogen worth $12.5M as of Q2 2026.
- TD Asset Management sold 69,463 Biogen shares in Q2 2026, an estimated $13.3M.
- Biogen made up 0.01% of TD Asset Management's portfolio in Q2 2026, its #606 holding.
- TD Asset Management first reported a position in Biogen in Q2 2013 and has held it in 53 quarters since.
- TD Asset Management's Biogen position peaked at $114M in Q1 2015.
- 842 funds tracked by Wall St. Rank held Biogen as of Q2 2026.
Based on TD Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.